In different clusters, symptom duration, severe myasthenia, cardiac involvement, serum inflammatory marker levels (ESR, CRP, C4), and CD163+ macrophage distribution were confirmed as discriminators. The gene discussed is ESR1; the disease is Fatigable weakness.